TABLE 1. Demographic characteristics, signs and symptoms, and underlying medical conditions among symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection (N = 409,462),*,† by pregnancy status — United States, January 22–October 3, 2020.
| Characteristic | No. (%) of symptomatic women |
||
|---|---|---|---|
| Pregnant (n = 23,434) | Nonpregnant (n = 386,028) | Total (N = 409,462) | |
|
Age group, yrs
| |||
| 15–24 |
6,463 (27.6) |
133,032 (34.5) |
139,495 (34.1) |
| 25–34 |
12,951 (55.3) |
131,835 (34.2) |
144,786 (35.4) |
| 35–44 |
4,020 (17.2) |
121,161 (31.4) |
125,181 (30.6) |
|
Race/Ethnicity
§
| |||
| Hispanic or Latina, any race |
6,962 (29.7) |
85,618 (22.2) |
92,580 (22.6) |
| AI/AN, non-Hispanic |
113 (0.5) |
1,652 (0.4) |
1,765 (0.4) |
| Asian, non-Hispanic |
560 (2.4) |
8,605 (2.2) |
9,165 (2.2) |
| Black, non-Hispanic |
3,387 (14.5) |
54,185 (14.0) |
57,572 (14.1) |
| NHPI, non-Hispanic |
119 (0.5) |
1,526 (0.4) |
1,645 (0.4) |
| White, non-Hispanic |
5,508 (23.5) |
124,305 (32.2) |
129,813 (31.7) |
| Multiple or other race, non-Hispanic |
726 (3.1) |
12,341 (3.2) |
13,067 (3.2) |
|
Signs and symptoms
| |||
| Known status of individual signs and symptoms¶ |
10,404 |
174,198 |
184,602 |
| Cough |
5,230 (50.3) |
89,422 (51.3) |
94,652 (51.3) |
| Fever** |
3,328 (32.0) |
68,536 (39.3) |
71,864 (38.9) |
| Muscle aches |
3,818 (36.7) |
78,725 (45.2) |
82,543 (44.7) |
| Chills |
2,537 (24.4) |
50,836 (29.2) |
53,373 (28.9) |
| Headache |
4,447 (42.7) |
95,713 (54.9) |
100,160 (54.3) |
| Shortness of breath |
2,692 (25.9) |
43,234 (24.8) |
45,926 (24.9) |
| Sore throat |
2,955 (28.4) |
60,218 (34.6) |
63,173 (34.2) |
| Diarrhea |
1,479 (14.2) |
38,165 (21.9) |
39,644 (21.5) |
| Nausea or vomiting |
2,052 (19.7) |
28,999 (16.6) |
31,051 (16.8) |
| Abdominal pain |
870 (8.4) |
16,123 (9.3) |
16,993 (9.2) |
| Runny nose |
1,328 (12.8) |
22,750 (13.1) |
24,078 (13.0) |
| New loss of taste or smell†† |
2,234 (21.5) |
43,256 (24.8) |
45,490 (24.6) |
| Fatigue |
1,404 (13.5) |
29,788 (17.1) |
31,192 (16.9) |
| Wheezing |
172 (1.7) |
3,743 (2.1) |
3,915 (2.1) |
| Chest pain |
369 (3.5) |
7,079 (4.1) |
7,448 (4.0) |
|
Underlying medical conditions
| |||
| Known underlying medical condition status§§ |
7,795 |
160,065 |
167,860 |
| Diabetes mellitus |
427 (5.5) |
6,119 (3.8) |
6,546 (3.9) |
| Cardiovascular disease |
304 (3.9) |
7,703 (4.8) |
8,007 (4.8) |
| Chronic lung disease |
506 (6.5) |
9,185 (5.7) |
9,691 (5.8) |
| Chronic renal disease |
18 (0.2) |
680 (0.4) |
698 (0.4) |
| Chronic liver disease |
17 (0.2) |
350 (0.2) |
367 (0.2) |
| Immunocompromised condition |
124 (1.6) |
2,496 (1.6) |
2,620 (1.6) |
| Neurologic disorder, neurodevelopmental disorder, or intellectual disability |
44 (0.6) |
1,097 (0.7) |
1,141 (0.7) |
| Psychiatric disorder |
62 (0.8) |
1,139 (0.7) |
1,201 (0.7) |
| Autoimmune disorder |
26 (0.3) |
515 (0.3) |
541 (0.3) |
| Severe obesity¶¶ | 174 (2.2) | 1,810 (1.1) | 1,984 (1.2) |
Abbreviations: AI/AN = American Indian or Alaska Native; NHPI = Native Hawaiian or Other Pacific Islander.
* Women with known pregnancy status, representing 52% of 783,072 total cases among symptomatic women aged 15–44 years.
† All statistical comparisons were significant at α <0.01, with the exception of the comparison of prevalence of neurologic disorders between pregnant and nonpregnant women (p = 0.307).
§ Race/ethnicity was missing for 6,059 (26%) of symptomatic pregnant women and 97,796 (26%) of symptomatic nonpregnant women.
¶ Data on individual symptoms were known for 10,404 (44%) of pregnant women and 174,198 (45%) of nonpregnant women. Individual symptoms were considered known if any of the following symptoms were noted as present or absent on the CDC’s Human Infection with 2019 Novel Coronavirus Case Report Form: fever (measured >100.4°F [38°C] or subjective), cough, shortness of breath, wheezing, difficulty breathing, chills, rigors, myalgia, rhinorrhea, sore throat, chest pain, nausea or vomiting, abdominal pain, headache, fatigue, diarrhea (three or more loose stools in a 24-hour period), new olfactory or taste disorder, or other symptom not otherwise specified on the form.
** Patients were included if they had information for either measured or subjective fever variables and were considered to have a fever if “yes” was indicated for either variable.
†† New olfactory and taste disorder has only been included on the CDC’s Human Infection with 2019 Novel Coronavirus Case Report Form since May 5, 2020. Therefore, data might be underreported for this symptom.
§§ Status was classified as “known” if any of the following conditions were noted as present or absent on the CDC’s Human Infection with 2019 Novel Coronavirus Case Report Form: diabetes mellitus, cardiovascular disease (including hypertension), severe obesity (body mass index ≥40 kg/m2), chronic renal disease, chronic liver disease, chronic lung disease, immunosuppressive condition, autoimmune condition, neurologic condition (including neurodevelopmental, intellectual, physical, visual, or hearing impairment), psychological/psychiatric condition, and other underlying medical condition not otherwise specified.
¶¶ Defined as body mass index ≥40 kg/m2.